Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles: 2019-2023

Historic Amortizatization of Intangibles for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Dec 2023 value amounting to $1.7 million.

  • Mirum Pharmaceuticals' Amortizatization of Intangibles fell 97.15% to $29,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.7 million, marking a year-over-year increase of 1.29%. This contributed to the annual value of $1.7 million for FY2023, which is 1.29% up from last year.
  • Mirum Pharmaceuticals' Amortizatization of Intangibles amounted to $1.7 million in FY2023, which was up 1.29% from $1.7 million recorded in FY2022.
  • Mirum Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $1.7 million for FY2023, and its period low was $137,000 during FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $1.7 million (2022), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Amortizatization of Intangibles plummeted by 56.92% in 2021, and later spiked by 1,143.07% in 2022.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Amortizatization of Intangibles stood at $326,000 in 2019, then fell by 2.45% to $318,000 in 2020, then crashed by 56.92% to $137,000 in 2021, then spiked by 1,143.07% to $1.7 million in 2022, then climbed by 1.29% to $1.7 million in 2023.